The Science

Why our process produces a more effective formula

Not all herbal formulas perform the same, and this is where most products fall short.

A formula may list the right botanicals, but efficacy depends entirely on which fraction of that plant is actually recovered. Research shows that extraction method, solvent choice, temperature, pH, particle size, and extraction time all determine which phytochemical fractions are captured, how stable they remain once isolated, and how biologically active they are in the final product. Most manufacturers optimize for yield and cost. We optimize for the bioactive fraction — the specific portion of the plant most associated with the therapeutic effect. That means deliberately selecting extraction parameters that target and preserve the compounds that actually do the work, not just the compounds that are easiest to pull out.

Once we have the right fraction, the second challenge is getting it into the skin. The skin barrier is designed to keep things out, and most topical formulas never solve this problem. Performance depends on the delivery system — solubility, release rate, penetration depth, and retention all vary significantly based on how a formula is built.

This is where our hybrid cream-serum fusion sets us apart. A traditional cream sits on the surface. A traditional serum penetrates but lacks the barrier-supporting lipids eczema-prone skin needs. Our formula is engineered to do both — the serum phase carries active ingredients past the surface barrier while the cream phase seals moisture in and supports barrier repair. The result is a delivery system that works with the skin rather than against it, designed specifically for the compromised barrier physiology that underlies eczema.

 

The ingredients and what the research shows

Coconut Oil — strongest direct evidence. Topical virgin coconut oil has been studied in atopic dermatitis for improving hydration, lowering transepidermal water loss, and reducing Staph aureus colonization. A clinical study recorded a 68.23% SCORAD improvement over 8 weeks in children with mild-to-moderate atopic dermatitis.

Aloe Vera and Aloe Polysaccharides — hydration and barrier support. Aloe components are studied for soothing hydration and may support tight-junction function, a key mechanism in how the barrier prevents water loss and allergen entry. A study recorded a 64.5% SCORAD improvement over 6 weeks in an atopic dermatitis cream study.

Lavender Extract — mechanistic support. Constituents including linalool and linalyl acetate have been studied for anti-inflammatory and antimicrobial activity. A lavender essential oil trial found up to a 97.7% lower chance of increased eczema severity by day 14.

Arnica — anti-inflammatory support. Arnica compounds have demonstrated skin penetration and anti-inflammatory activity in experimental skin studies, supporting the formula's ability to calm redness and visible irritation.

Ivy Extract — supportive phytochemical role. Ivy phytochemicals are studied for antioxidant and anti-inflammatory activity. A wound-healing model using Hedera helix recorded 95.82% wound contraction, reflecting strong tissue-repair potential. Eczema-specific human evidence is still emerging.

 

Why eczema happens

Eczema isn't just dry skin. It begins with a compromised skin barrier that lets irritants and allergens in while moisture escapes through a process called transepidermal water loss (TEWL). That triggers Type 2 immune signaling, producing the redness, itch, and flare-ups most people recognize. Environmental triggers and Staph aureus overgrowth make the cycle worse, and scratching injures the barrier further, keeping the skin locked in a pattern of irritation and repair.

There are four core drivers at work: barrier dysfunction, where lipid-barrier weakness lets moisture escape and irritants enter; immune dysregulation, where Type 2 inflammation drives redness, itch, and recurring flare-ups; external triggers and microbial imbalance, where allergens, dry environments, and Staph aureus worsen symptoms; and the itch-scratch cycle, where scratching re-injures the barrier and prolongs inflammation.

Our cream-serum works by addressing all four of these drivers together — hydrating the surface, supporting the barrier to reduce TEWL, calming irritated-looking skin, and helping keep Staph aureus in check with each application.

 

The bottom line

Eczema-prone skin is driven by barrier weakness, inflammation, and external triggers. Ingredient quality matters, but it is not enough on its own. The fraction of the plant you extract, and the system you use to deliver it, determine whether a formula actually works. Our process is built around both — targeting the bioactive fraction most associated with efficacy, then delivering it through a hybrid cream-serum system designed for compromised skin.